The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for valvular disease and heart failure
Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI)
Rodrigo Estevez-Loureiro1, MD, PhD; Marianna Adamo2, MD, PhD; Dabit Arzamendi3, MD, PhD; Paolo Denti4, MD, PhD; Xavier Freixa5, MD, PhD; Luis Nombela-Franco6, MD, PhD; Isaac Pascual7, MD, PhD; Bruno Melica8, MD; David Attias9, MD; Ana Serrador10, MD, PhD; Tomas Benito-González11, MD; Andres Iñiguez1, MD, PhD; Felipe Fernández-Vázquez11, MD, PhD; on behalf of EREMMI Investigators
1. Interventional Cardiology Unit, Hospital Álvaro Cunqueiro, Vigo, Spain; 2. Cardiac Catheterization Laboratory, Cardiothoracic Department, Spedali Civili, Brescia, Italy; 3. Interventional Cardiology Unit, Hospital Sant Pau i Santa Creu, Barcelona, Spain; 4. Department of Cardiovascular Surgery, San Raffaele University Hospital, Milan, Italy; 5. nterventional Cardiology Unit, Hospital Clinic, Barcelona, Spain; 6. Interventional Cardiology Unit, Hospital Clinico San Carlos, Madrid, Spain; 7. Interventional Cardiology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain; 8. Serviço de Cardiologia, Centro Hospitalar de Vila Nova de Gaia/Espinho-EPE, Vila Nova de Gaia, Portugal; 9. Department of Cardiology, Centre Cardiologique du Nord, Saint Denis, France; 10. Interventional Cardiology Unit, Hospital Clinico Universitario de Valladolid, Valladolid, Spain; 11. Interventional Cardiology Unit, Complejo Asistencial Universitario de Leon, Leon, Spain
Introduction
Acute mitral regurgitation (MR) may develop in the setting of an acute myocardial infarction (AMI) as a result of papillary muscle dysfunction or rupture. Acute ischaemic MR without papillary muscular rupture may induce severe MR due to leaflet tethering produced by the sudden onset of regional or global left ventricular dysfunction. This can lead to pulmonary oedema or cardiogenic shock during the acute or subacute phase of the MI1. Although previous experience with the MitraClip® (Abbott Vascular, Santa Clara, CA, USA) for correcting MR following AMI has been reported2, data on consecutive patients treated for this ...
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
Midterm procedural and clinical outcomes of percutaneous paravalvular leak closure with the Occlutech Paravalvular Leak Device
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022